A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML

To effectively improve treatment for acute myeloid leukemia (AML), new molecular targets and therapeutic approaches need to be identified. Chimeric antigen receptor (CAR)-modified T cells targeting tumor-associated antigens have shown promise in the treatment of some malignancies. However, CAR-T cel...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Ther
Autori principali: John, Samuel, Chen, Heyu, Deng, Mi, Gui, Xun, Wu, Guojin, Chen, Weina, Li, Zunling, Zhang, Ningyan, An, Zhiqiang, Zhang, Cheng Cheng
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Gene & Cell Therapy 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6171100/
https://ncbi.nlm.nih.gov/pubmed/30131301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2018.08.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi